Robert Andrew Quinn

Associate Professor, Department of Biochemistry & Molecular Biology
Associate Professor, Department of Microbiology, Genetics, & Immunology
Assistant Professor, BioMolecular Science Gateway
Location: 120 Biochemistry
Profile photo of  Robert Andrew Quinn
Photo of: Robert Andrew Quinn

Bio

The human microbiome is a consortium of microorganisms living on and in our bodies. These microbial symbionts contribute to our health and homeostasis, but sometimes, the microbiome becomes perturbed resulting in dysbiosis and chronic disease. Understanding how changes in our microbiome lead to disease has immense implications for human health. Our laboratory studies how metabolites from the microbiome shape our health and disease.

We focus our research on the cystic fibrosis (CF) lung microbiome to understand how bacteria living in the lungs of CF patients cause disease, but also study the gut microbiome and microbial communities associated with marine organisms, fermented foods and anything else we find interesting. Using mass spectrometry-based metabolomics, nucleic acid sequencing, and novel microbial culture techniques, our work has shown how changes in metabolite production from the microbiome lead to acute flares of chronic disease. In the CF lung for example, changes in the core metabolism of the microbiome to anaerobic fermentation results in the production of acidic products that damage the lung. In the human gut, bacteria alter molecules we consume in our food and also those that we produce, such as bile acids, however, we have little understanding of how these molecules affect human health. 

My laboratory also focuses on translating bioinformatic tools to clinical medicine. The software and data analysis pipelines developed for microbiome and metabolome research are now so advanced that this big-data science can be done in clinically relevant timeframes. We use metabolomics and microbiome sequencing as a precision medicine approach for microbiome-related diseases with sample-to-data turnaround times as fast as 48 hours. By combining multi-omics tools with microbial ecology theory, we aim to understand the causes of microbiome dysbioses and develop new therapeutic approaches to manipulate the microbiome to benefit human health.

# Education
* Ph.D. 2012, Environmental and Evolutionary Biology, University of Louisiana at Lafayette, Lafayette, LA
* M.Sc. 2008, Microbiology, University of Guelph, Guelph, Ontario, Canada
* B.Sc. 2005, Microbiology, University of Guelph, Guelph, Ontario, Canada

# Links
* [Robert Quinn Lab Website](https://www.robertquinnlab.com/)
* [Current Research](https://bmb.natsci.msu.edu/directory-pages/faculty/robert-quinn/current-research.aspx)
* [Recent Publications](https://bmb.natsci.msu.edu/directory-pages/faculty/robert-quinn/recent-publications.aspx)
* [Google Scholar Citations](https://scholar.google.com/citations?hl=en&user=xn7bbDgAAAAJ)

Courses

  • MGI 499: Undergraduate Research